Neuren Pharmaceuticals | NEU - EPS Earnings Per Share


Neuren Pharmaceuticals reported AUD0.12 in EPS Earnings Per Share for its fiscal semester ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
0.04 32.00 0.12 Aug/25




Eps Change Date
Akebia Therapeutics USD -0.04 0.04 Dec/2025
Alaunos Therapeutics USD -0.52 0.02 Mar/2026
Avita Medical AUD -0.38 0 Dec/2025
Clinuvel Pharmaceuticals AUD 0.21 0.23 Dec/2025
Dianthus Therapeutics USD -0.85 0.58 Mar/2026
Genetic Signatures AUD -0.03 0.02 Dec/2025
Ionis Pharmaceuticals USD -0.69 0.13 Jun/2026
Medical Developments International AUD 0 0 Dec/2025
Neuren Pharmaceuticals AUD 0.12 0.06 Dec/2025
Organon & Co USD 0.4 0.31 Jun/2026
Paradigm Biopharmaceuticals AUD -0.06 0.03 Dec/2025
PYC Therapeutics AUD -0.04 0.01 Dec/2025
Starpharma Holdings AUD 0 0.01 Dec/2025
Tectonic Therapeutic USD -1.34 0.32 Mar/2026
Telix Pharmaceuticals AUD 0.1 0.16 Jun/2026
Viatris USD 0.69 0.1 Jun/2026
Xeris Pharmaceuticals USD 0.01 0.04 Mar/2026